Multiple Assemblies exist for SMTL entry 2v7a
Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358; X-RAY DIFFRACTION 2.50 Å

	SMTL ID 2v7a.1 Ligands N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE; MAGNESIUM ION Polypeptides PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 Oligo-state monomer
	SMTL ID 2v7a.2 Ligands N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE; MAGNESIUM ION Polypeptides PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 Oligo-state monomer